Description

The company’s patented hemodialysis device selectively captures, treats, or removes target pathogens e.g. cells, virus, toxins, and antibodies. This is unlike other hemodialysis devices that focus on dialysis with limited innovative treatments. This device combines cutting edge biotech innovations with hemodialysis. The device uses antibody/ligand mediated target capture. Hospital and dialysis centers can use the device to treat other diseases such as metastatic cancer, autoimmune disease, viral infections, and sepsis.

Posted Oct 12, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.